People taking GLP-1 weight loss drugs like Ozempic started moving less — Live Feedhttps://www.live-feeds.com/feed/people-taking-glp-1-weight-loss-drugs-like-ozempic-started-moving-lessContinuously updated, source-cited coverage. GLP-1 drugs like Ozempic linked to sharp drop in movement despite weight losshttps://www.live-feeds.com/feed/people-taking-glp-1-weight-loss-drugs-like-ozempic-started-moving-lesshttps://www.live-feeds.com/feed/people-taking-glp-1-weight-loss-drugs-like-ozempic-started-moving-less#u1256Tue, 16 Jun 2026 13:42:08 +0000Multiple studies confirm users of GLP-1 weight-loss medications—including Ozempic, Wegovy, Mounjaro, and Zepbound—reduce daily steps and exercise levels even as they lose weight. Researchers warn this decline in physical activity may weaken muscle mass and long-term health. A multinational study further shows exercise combined with GLP-1 therapy yields better sustained benefits. Experts urge patients to maintain activity to offset muscle loss.What's confirmed:Users of GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound show significant drops in daily step counts and exercise levels after